...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >ENHANCEMENT OF SOLUBILITY AND OPTIMIZATION OF ORALLY DISINTEGRATING FILMS OF ACYCLOVIR
【24h】

ENHANCEMENT OF SOLUBILITY AND OPTIMIZATION OF ORALLY DISINTEGRATING FILMS OF ACYCLOVIR

机译:无环藻胶的可溶性增强和正交分解膜的优化

获取原文
           

摘要

Objective: The objective of this work was to prepare and optimize orally disintegrating films of acyclovir (ACV), which is a known antiviral agent. To enhance the solubility of ACV, solid dispersions of ACV were made. Methods: The films were prepared using a solvent casting technique. Full factorial design was utilized for the optimization of the effect of independent variables such as the amount of hydroxypropyl methylcellulose 5 cps, sodium starch glycolate, and propylene glycol on the disintegration time. Other evaluation tests such as drug release, drug content, thickness, and folding endurance of film were also conducted. Results: Compatibility studies by Fourier transform infrared showed that there was no significant interaction between the drug and excipients used. Disintegration time was found to be 43 s for the optimized batch. The in vitro release profile of formulation response disintegrating time in phosphate buffer pH 6.8 revealed that there was a significant increment in drug release of the optimized batch in comparison to the screening batches. Further, short-term accelerated stability studies carried out for 4 weeks for the optimized formulation which proved that the formulated films were stable at the accelerated conditions of temperature and humidity (40±2°C/75±5% RH). Conclusions: It was concluded that such ACV solid dispersion films could be beneficial in enhancement of dissolution and consequently the oral bioavailability of ACV.
机译:目的:这项工作的目的是制备和优化阿昔洛韦(ACV)的口腔崩解膜,这是一种已知的抗病毒药物。为了提高ACV的溶解度,制备了ACV的固体分散体。方法:使用溶剂流延技术制备薄膜。利用全因子设计来优化独立变量(例如5 cps的羟丙基甲基纤维素的量,羟乙酸淀粉钠和丙二醇的量)对崩解时间的影响。还进行了其他评估测试,例如药物释放,药物含量,厚度和薄膜的耐折性。结果:通过傅立叶变换红外光谱进行的兼容性研究表明,药物与所用赋形剂之间没有明显的相互作用。发现优化批次的崩解时间为43 s。在磷酸盐缓冲液pH 6.8中,制剂响应崩解时间的体外释放曲线表明,与筛选批次相比,优化批次的药物释放显着增加。此外,针对优化配方进行了为期4周的短期加速稳定性研究,结果证明该配方薄膜在温度和湿度(40±2°C / 75±5%RH)的加速条件下是稳定的。结论:结论是,这样的ACV固体分散膜可能有利于增强ACV的溶出度,从而增强ACV的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号